Evidence map›Paper›PMID 29854952›Full record

ArticleScience advances2018

Dynamical features in fetal and postnatal zinc-copper metabolic cycles predict the emergence of autism spectrum disorder.

Paul Curtin, Christine Austin, Austen Curtin, Chris Gennings, Manish Arora, (for the Emergent Dynamical Systems Group), Kristiina Tammimies, Charlotte Willfors, Steve Berggren, Paige Siper and 12 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Early-life dentine-based elemental biodynamics and cord blood telomere length.medRxiv : the preprint server for health sciences · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Paul CurtinDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
Christine AustinDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.ORCID 0000-0002-9966-0492
Austen CurtinDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
Chris GenningsDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
Manish AroraDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
(for the Emergent Dynamical Systems Group)
Kristiina TammimiesCenter of Neurodevelopmental Disorders, Division of Neuropsychiatry, Department of Women's and Children's Health, Karolinska Institutet, Floor 8, Gävlegatan 22, SE-11330 Stockholm, Sweden.ORCID 0000-0002-8324-4697
Charlotte WillforsCenter of Neurodevelopmental Disorders, Division of Neuropsychiatry, Department of Women's and Children's Health, Karolinska Institutet, Floor 8, Gävlegatan 22, SE-11330 Stockholm, Sweden.ORCID 0000-0001-8775-6537
Steve BerggrenCenter of Neurodevelopmental Disorders, Division of Neuropsychiatry, Department of Women's and Children's Health, Karolinska Institutet, Floor 8, Gävlegatan 22, SE-11330 Stockholm, Sweden.ORCID 0000-0002-3040-911X
Paige SiperDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Dheeraj RaiCentre for Academic Mental Health, School of Social and Community Medicine, University of Bristol, Bristol, England.ORCID 0000-0002-7239-3523
Kristin MeyeringDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Alexander KolevzonDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Josephine MollonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England.
Anthony S DavidDepartment of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, England.ORCID 0000-0003-0967-774X
Glyn LewisDivision of Psychiatry, Faculty of Brain Sciences, University College London, Maple House, London, England.ORCID 0000-0001-5205-8245
Stanley ZammitCentre for Academic Mental Health, School of Social and Community Medicine, University of Bristol, Bristol, England.
Lynne HeilbrunFamily and Community Medicine, School of Medicine, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.ORCID 0000-0002-3957-8809
Raymond F PalmerFamily and Community Medicine, School of Medicine, University of Texas Health Sciences Center, San Antonio, TX 78229, USA.ORCID 0000-0001-6621-9038
Robert O WrightDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
Sven BölteCenter of Neurodevelopmental Disorders, Division of Neuropsychiatry, Department of Women's and Children's Health, Karolinska Institutet, Floor 8, Gävlegatan 22, SE-11330 Stockholm, Sweden.ORCID 0000-0002-4579-4970
Abraham ReichenbergDepartment of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1057, New York, NY 10029, USA.
Icahn School of Medicine at Mount Sinai · USKing's College London · GBStockholm County Council · SEThe University of Texas Health Science Center at San Antonio · USUniversity of Bristol · GB

Funding

MSHS Translational Science HubUL1TR001433 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROSALIND J · 2015 to 2019
$26.6M
Statistical Services and Methods Development ResourceU2CES026555 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI TEITELBAUM, SUSAN L · 2015 to 2025
$26.4M
Untargeted Analysis ResourceU2CES026561 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WRIGHT, ROBERT O · 2015 to 2025
$24.5M
The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Maria Jose Rosa · 2014 to 2026
$21.3M
Toward better characterization and clinical trial readiness for targeting neuropsychiatric manifestations in PTEN pathogenic variantsU54NS092090 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI M. Pilar Trelles · 2014 to 2026
$20.1M
Stress, Lead, Iron Deficiency and NeurodevelopmentR01ES013744 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Robert O Wright · 2007 to 2026
$13.4M
Organic-metal mixtures and neurodevelopmentR01ES026033 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Manish Arora, Robert O Wright · 2016 to 2026
$6.1M
Reconstructing fetal toxicant exposure and homeostatic disruptionsDP2ES025453 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARORA, MANISH · 2014 to 2019
$2.6M
Prenatal Timing of Heavy Metal Exposures from Autistic and Non-Autistic ChildrenR21ES023604 · NIEHS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ARORA, MANISH, PALMER, RAYMOND F · 2014 to 2015
$426k
Determining the Neurodevelopmental Effects of Transition from Breastfeeding to Infant Formula using a Novel BiomarkerK99HD087523 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AUSTIN, CHRISTINE · 2017 to 2018
$215k
NIEHS NIH HHS DP2 ES025453NIEHS NIH HHS P30 ES023515NIEHS NIH HHS R01 ES013744NIEHS NIH HHS R01 ES026033NIEHS NIH HHS R21 ES023604NIEHS NIH HHS U2C ES026555NIEHS NIH HHS U2C ES026561NINDS NIH HHS U54 NS092090Wellcome Trust
6 · The paper itself

Abstract

Metals are critical to neurodevelopment, and dysregulation in early life has been documented in autism spectrum disorder (ASD). However, underlying mechanisms and biochemical assays to distinguish ASD cases from controls remain elusive. In a nationwide study of twins in Sweden, we tested whether zinc-copper cycles, which regulate metal metabolism, are disrupted in ASD. Using novel tooth-matrix biomarkers that provide direct measures of fetal elemental uptake, we developed a predictive model to distinguish participants who would be diagnosed with ASD in childhood from those who did not develop the disorder. We replicated our findings in three independent studies in the United States and the UK. We show that three quantifiable characteristics of fetal and postnatal zinc-copper rhythmicity are altered in ASD: the average duration of zinc-copper cycles, regularity with which the cycles recur, and the number of complex features within a cycle. In all independent study sets and in the pooled analysis, zinc-copper rhythmicity was disrupted in ASD cases. In contrast to controls, in ASD cases, the cycle duration was shorter (

Indexed as

Autism Spectrum DisorderBiomarkersCase-Control StudiesChildCopperFemaleHumansMaleMass SpectrometryPregnancyPrognosisROC CurveSensitivity and SpecificityZincBiomarkersCopperZinc

Identifiers

PMID29854952
PMCPMC5976276
OpenAlexW2806188324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.